19-39707285-G-A

Variant summary

Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_020129.3(LGALS14):​c.200G>A​(p.Cys67Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000954 in 1,613,960 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C67R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00053 ( 2 hom., cov: 32)
Exomes 𝑓: 0.000051 ( 0 hom. )

Consequence

LGALS14
NM_020129.3 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -1.48
Variant links:
Genes affected
LGALS14 (HGNC:30054): (galectin 14) This gene is predominantly expressed in placenta. The encoded protein belongs to the galectin (galaptin/S-lectin) family. The members of galectin family contain one or two carbohydrate recognition domains, which can bind beta-galactoside. Two alternatively spliced transcript variants encoding distinct isoforms have been observed. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.00476861).
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LGALS14NM_020129.3 linkc.200G>A p.Cys67Tyr missense_variant 3/4 ENST00000392052.8 NP_064514.1 Q8TCE9-1
LGALS14NM_203471.2 linkc.287G>A p.Cys96Tyr missense_variant 4/5 NP_982297.1 Q8TCE9-2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LGALS14ENST00000392052.8 linkc.200G>A p.Cys67Tyr missense_variant 3/41 NM_020129.3 ENSP00000375905.2 Q8TCE9-1
LGALS14ENST00000360675.7 linkc.287G>A p.Cys96Tyr missense_variant 4/53 ENSP00000353893.2 Q8TCE9-2
LGALS14ENST00000601802.1 linkc.149G>A p.Cys50Tyr missense_variant 2/35 ENSP00000471660.1 M0R163

Frequencies

GnomAD3 genomes
AF:
0.000526
AC:
80
AN:
152224
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.0833
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000279
AC:
7
AN:
251064
Hom.:
0
AF XY:
0.0000295
AC XY:
4
AN XY:
135666
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000980
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000353
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000506
AC:
74
AN:
1461736
Hom.:
0
Cov.:
33
AF XY:
0.0000536
AC XY:
39
AN XY:
727178
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000812
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000558
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.000526
AC:
80
AN:
152224
Hom.:
2
Cov.:
32
AF XY:
0.000511
AC XY:
38
AN XY:
74370
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.000808
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000247
AC:
3
EpiCase
AF:
0.000164
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 01, 2024The c.287G>A (p.C96Y) alteration is located in exon 4 (coding exon 3) of the LGALS14 gene. This alteration results from a G to A substitution at nucleotide position 287, causing the cysteine (C) at amino acid position 96 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.77
CADD
Benign
0.062
DANN
Benign
0.27
DEOGEN2
Benign
0.0043
T;.
Eigen
Benign
-1.5
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.0013
N
LIST_S2
Benign
0.52
T;T
M_CAP
Benign
0.00064
T
MetaRNN
Benign
0.0048
T;T
MetaSVM
Benign
-0.91
T
MutationAssessor
Benign
0.065
N;.
PrimateAI
Benign
0.33
T
PROVEAN
Benign
0.85
N;N
REVEL
Benign
0.0060
Sift
Benign
1.0
T;T
Sift4G
Benign
0.51
T;T
Polyphen
0.0
B;.
Vest4
0.12
MVP
0.15
MPC
0.18
ClinPred
0.041
T
GERP RS
-2.1
Varity_R
0.14
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs757265795; hg19: chr19-40197925; API